Company / Current Assets per Share
Oric Pharmaceuticals, Inc. Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$3.29
FY2025
5-year range
$3.29 / $6.34
FY2021-FY2025
Trend
-12.6%
vs FY2024
Sector context
#157 of 210
Health Care
What the data says
Oric Pharmaceuticals, Inc.'s current assets per share of $3.29 is lower than 75% of companies in the Health Care sector (FY2025). Current Assets per Share has declined for 6 consecutive years, from $47.38 in FY2019 to $3.29 in FY2025.
Based on SEC 10-K filings.
3.29 in FY2025 with a 5-year CAGR of -24.6%.
Declined from $4.13 to $3.29 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -14.8%
- 5-Year CAGR
- -24.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 210This company $3.29 Sector average $170.65
▼
-98.1% below sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s current assets per share has declined for 6 consecutive years.
- In FY2025, current assets per share decreased 12.6% year-over-year.
- Ranks #157 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.29 | -12.6% |
| FY2024 | $3.76 | -9.0% |
| FY2023 | $4.13 | -22.1% |
| FY2022 | $5.31 | -16.3% |
| FY2021 | $6.34 | -53.1% |
| FY2020 | $13.52 | -71.5% |
| FY2019 | $47.38 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026